BACKGROUND: The delivery of excess maternal nutrients to the fetus is known to increase the risk of macrosomia, even among infants of women without gestational diabetes mellitus. With the current obesity epidemic, maternal adiposity and its associated effects on circulating adipokines and inflammatory proteins may now have a greater impact on fetal growth. We sought to evaluate the independent effects of maternal glycemia, lipids, obesity, adipokines and inflammation on infant birth weight. METHODS: We included 472 women who underwent an oral glucose tolerance test in late pregnancy and were found not to have gestational diabetes; 104 (22.0%) had gestational impaired glucose tolerance. We also measured fasting levels of insulin, low-and high-density lipoprotein cholesterol, triglycerides, leptin, adiponectin and C-reactive protein. Obstetric outcomes were assessed at delivery. RESULTS: The mean birth weight was 3481 g (standard deviation 493 g); 68 of the infants were large for gestational age. On multiple linear regression analysis, positive determinants of birth weight were length of gestation, male infant, weight gain during pregnancy up to the time of the oral glucose tolerance test, body mass index (BMI) before pregnancy and impaired glucose tolerance in pregnancy. Leptin, adiponectin and C-reactive protein levels were each negatively associated with birth weight. On logistic regression analysis, the significant metabolic predictors of having a large-for-gestational-age infant were BMI before pregnancy (odds ratio [OR] 1.16, 95% confidence interval [CI] 1.05-1.27, per 1 kg/m(2) increase), weight gain during pregnancy up to the time of the oral glucose tolerance test (OR 1.12, 95% CI 1.05-1.19, per 1 kg increase) and leptin level (OR 0.50, 95% CI 0.30-0.82, per 1 standard deviation change). INTERPRETATION: Among women without gestational diabetes, maternal adiposity and leptin levels were the strongest metabolic determinants of having a large-for-gestational-age infant rather than glucose intolerance and lipid levels.
BACKGROUND: The delivery of excess maternal nutrients to the fetus is known to increase the risk of macrosomia, even among infants of women without gestational diabetes mellitus. With the current obesity epidemic, maternal adiposity and its associated effects on circulating adipokines and inflammatory proteins may now have a greater impact on fetal growth. We sought to evaluate the independent effects of maternal glycemia, lipids, obesity, adipokines and inflammation on infant birth weight. METHODS: We included 472 women who underwent an oral glucose tolerance test in late pregnancy and were found not to have gestational diabetes; 104 (22.0%) had gestational impaired glucose tolerance. We also measured fasting levels of insulin, low-and high-density lipoprotein cholesterol, triglycerides, leptin, adiponectin and C-reactive protein. Obstetric outcomes were assessed at delivery. RESULTS: The mean birth weight was 3481 g (standard deviation 493 g); 68 of the infants were large for gestational age. On multiple linear regression analysis, positive determinants of birth weight were length of gestation, male infant, weight gain during pregnancy up to the time of the oral glucose tolerance test, body mass index (BMI) before pregnancy and impaired glucose tolerance in pregnancy. Leptin, adiponectin and C-reactive protein levels were each negatively associated with birth weight. On logistic regression analysis, the significant metabolic predictors of having a large-for-gestational-age infant were BMI before pregnancy (odds ratio [OR] 1.16, 95% confidence interval [CI] 1.05-1.27, per 1 kg/m(2) increase), weight gain during pregnancy up to the time of the oral glucose tolerance test (OR 1.12, 95% CI 1.05-1.19, per 1 kg increase) and leptin level (OR 0.50, 95% CI 0.30-0.82, per 1 standard deviation change). INTERPRETATION: Among women without gestational diabetes, maternal adiposity and leptin levels were the strongest metabolic determinants of having a large-for-gestational-age infant rather than glucose intolerance and lipid levels.
Authors: M S Kramer; R W Platt; S W Wen; K S Joseph; A Allen; M Abrahamowicz; B Blondel; G Bréart Journal: Pediatrics Date: 2001-08 Impact factor: 7.124
Authors: W Ricart; J López; J Mozas; A Pericot; M A Sancho; N González; M Balsells; R Luna; A Cortázar; P Navarro; O Ramírez; B Flández; L F Pallardo; A Hernández-Mijas; J Ampudia; J M Fernández-Real; R Corcoy Journal: Diabetologia Date: 2005-07-29 Impact factor: 10.122
Authors: G Di Cianni; R Miccoli; L Volpe; C Lencioni; A Ghio; M G Giovannitti; I Cuccuru; G Pellegrini; K Chatzianagnostou; A Boldrini; S Del Prato Journal: Diabet Med Date: 2005-01 Impact factor: 4.359
Authors: M Sermer; C D Naylor; D J Gare; A B Kenshole; J W Ritchie; D Farine; H R Cohen; K McArthur; S Holzapfel; A Biringer Journal: Am J Obstet Gynecol Date: 1995-07 Impact factor: 8.661
Authors: K M Renault; E M Carlsen; S Hædersdal; L Nilas; N J Secher; J Eugen-Olsen; D Cortes; S F Olsen; T I Halldorsson; K Nørgaard Journal: Int J Obes (Lond) Date: 2017-01-17 Impact factor: 5.095
Authors: Melissa E Heard-Lipsmeyer; Eva C Diaz; Clark R Sims; Sarah R Sobik; Meghan L Ruebel; Keshari M Thakali; Rebecca A Krukowski; Mario Cleves; Elisabet Børsheim; Kartik Shankar; Aline Andres Journal: Obesity (Silver Spring) Date: 2020-02-06 Impact factor: 5.002
Authors: Eric Lavigne; Jillian Ashley-Martin; Linda Dodds; Tye E Arbuckle; Perry Hystad; Markey Johnson; Dan L Crouse; Adrienne S Ettinger; Gabriel D Shapiro; Mandy Fisher; Anne-Sophie Morisset; Shayne Taback; Maryse F Bouchard; Liu Sun; Patricia Monnier; Renée Dallaire; William D Fraser Journal: Am J Epidemiol Date: 2016-03-29 Impact factor: 4.897
Authors: A J Yeates; E M McSorley; M S Mulhern; T Spence; W Crowe; K Grzesik; S W Thurston; G E Watson; G J Myers; P W Davidson; C F Shamlaye; E van Wijngaarden; J J Strain Journal: J Reprod Immunol Date: 2019-10-23 Impact factor: 4.054
Authors: Lauren E McCullough; Erline E Miller; Laura E Calderwood; Nitin Shivappa; Susan E Steck; Michele R Forman; Michelle A Mendez; Rachel Maguire; Bernard F Fuemmeler; Scott H Kollins; Staci D Bilbo; Zhiqing Huang; Amy P Murtha; Susan K Murphy; James R Hébert; Cathrine Hoyo Journal: Epigenetics Date: 2017-07-05 Impact factor: 4.528
Authors: P T Katzmarzyk; S Barlow; C Bouchard; P M Catalano; D S Hsia; T H Inge; C Lovelady; H Raynor; L M Redman; A E Staiano; D Spruijt-Metz; M E Symonds; M Vickers; D Wilfley; J A Yanovski Journal: Int J Obes (Lond) Date: 2014-03-25 Impact factor: 5.095